NPPA reduces prices of essential drugs by more than 50% in March-Oct 2016

With an aim to provide affordable and cost-effective drugs to people, the National Pharmaceutical Pricing Authority (NPPA) has reduced prices of drugs by more than 50% in the seven months last year.

NPPA on Tuesday tweeted list of 23 essential medicines under NLEM 2015 of which prices were reduced for more than 50% from March to October 2016.

List of drugs (from March,16 to Oct,2016) with price reduction of more than 50% pic.twitter.com/0buOecXzWZ

— NPPAindia (@nppa_india) March 7, 2017

NPPA is the government agency under the department of pharmaceuticals which controls the prices of drugs in India. 

ALSO READ: Hepatitis C drug prices in India unaffected by patent: Gilead

Similarly, the drug pricing control agency has reduced prices of 75 drugs under National List of Essential Medicines (NLEM) on October last year in the range of 30% to 50%.

List of NLEM,15 drugs with price reduction between 30-50%, as on Oct.2016 pic.twitter.com/P6T3bMxmn1

— NPPAindia (@nppa_india) March 7, 2017

Moreover, the agency has brought down prices of cardiovascular disease drugs manufactured by top brands like Lupin, Micro Labs, Sanofi India, Zydus Cadila, Ranbaxy Laboratories, among others in the range of 13% to 42% since March last year.

Top brands of cardiovascular disease drugs brought under price control since March,2016 pic.twitter.com/dLYysBtIRf

— NPPAindia (@nppa_india) March 6, 2017

ALSO READ: India to revise drugs law, draft new rules for medical devices